Hi all, l would appreciate clarification on whether type 2 diabetes reduces the threshold for neurodegeneration in Alzheimer disease (AD) from clinical perspective as it does when it is induced in preclinical models of AD? This was noted in this review: https://pubmed.ncbi.nlm.nih.gov/30022099

Also, l would like to ask if clinically, there are differences in the severity in cognitive dysfunctions due to AD and cognitive dysfunctions due to Type-2 Diabetes (T2D) or a co-morbidity of AD and T2D

More Joshua Adekunle Babalola's questions See All
Similar questions and discussions